ReP USP - Resultado da busca

Artigo de periodico
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Silva, Wellington Fernandes da; Nascimento, Mariane Cristina do ; Miranda, Lívia Bassani Lins De ; Medeiros, Rita de Cássia Cavaglieri ; Nardinelli, Luciana; Leal, Aline de Medeiros; Velloso, Elvira Deolinda Rodrigues Pereira ; Bendit, Israel ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FM, ICB, FMRP
Subjects: HEMATOLOGIA, LEUCEMIA, LINFOMA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, INIBIDORES QUÍMICOS, ESTUDOS DE COORTES, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING, CITOMETRIA DE FLUXO, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. Blood, v. 142, p. 5886, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189786. Acesso em: 03 jun. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Martins, D. A. P., Silva, W. F. da, Nascimento, M. C. do, Miranda, L. B. L. D., et al. (2023). Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. Blood, 142, 5886. doi:10.1182/blood-2023-189786
NLM
Lima KC de, Carvalho MFL, Martins DAP, Silva WF da, Nascimento MC do, Miranda LBLD, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Schuringa JJ, Rego EM, Machado Neto JA. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. Blood. 2023 ; 142 5886.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-189786
Vancouver
Lima KC de, Carvalho MFL, Martins DAP, Silva WF da, Nascimento MC do, Miranda LBLD, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Schuringa JJ, Rego EM, Machado Neto JA. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. Blood. 2023 ; 142 5886.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-189786
Artigo de periodico
Autophagy induction constitutes a targetable vulnerability in FLT3-mutant acute Myeloid Leukemia cells treated with FLT3-inhibitors (2023)
Melo, Manuela Albuquerque de ; Macedo, Brunno Gilberto Santos ; Fonseca, Natasha Peixoto ; Scheucher, Priscila Santos ; Martins, Diego Antonio Pereira ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FMRP, ICB
Subjects: FARMACOLOGIA, HEMATOLOGIA, CÉLULAS MIELOIDES, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Manuela Albuquerque de et al. Autophagy induction constitutes a targetable vulnerability in FLT3-mutant acute Myeloid Leukemia cells treated with FLT3-inhibitors. Blood, v. 142, n. Supl. 1, p. 5752, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-190724. Acesso em: 03 jun. 2024.
APA
Melo, M. A. de, Macedo, B. G. S., Fonseca, N. P., Scheucher, P. S., Martins, D. A. P., Traina, F., & Machado Neto, J. A. (2023). Autophagy induction constitutes a targetable vulnerability in FLT3-mutant acute Myeloid Leukemia cells treated with FLT3-inhibitors. Blood, 142( Supl. 1), 5752. doi:10.1182/blood-2023-190724
NLM
Melo MA de, Macedo BGS, Fonseca NP, Scheucher PS, Martins DAP, Traina F, Machado Neto JA. Autophagy induction constitutes a targetable vulnerability in FLT3-mutant acute Myeloid Leukemia cells treated with FLT3-inhibitors [Internet]. Blood. 2023 ; 142( Supl. 1): 5752.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-190724
Vancouver
Melo MA de, Macedo BGS, Fonseca NP, Scheucher PS, Martins DAP, Traina F, Machado Neto JA. Autophagy induction constitutes a targetable vulnerability in FLT3-mutant acute Myeloid Leukemia cells treated with FLT3-inhibitors [Internet]. Blood. 2023 ; 142( Supl. 1): 5752.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-190724
Artigo de periodico
Differential diagnosis of bone marrow failure syndromes guided by machine learning (2023)
Gutierrez-Rodrigues, Fernanda ; Munger, Eric; Ma, Xiaoyang; Patel, Bhavisha A; Catto, Luiz Fernando Bazzo ; Clé, Diego Villa ; Paiva, Raquel de Melo Alves ; Donaires, Flávia Sacilotto ; Pinto, André Luiz; Borges, Gustavo; Santana, Bárbara Amélia Aparecida ; Pasquini, Ricardo; Velloso, Elvira Deolinda Rodrigues Pereira ; Calado, Rodrigo Tocantins
Source: Blood. Unidades: FMRP, FM
Subjects: ANEMIA, DOENÇAS DA MEDULA ÓSSEA, DIAGNÓSTICO DIFERENCIAL, HEMOGLOBINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ-RODRIGUES, Fernanda et al. Differential diagnosis of bone marrow failure syndromes guided by machine learning. Blood, v. 141, n. 17, p. 2100-2113, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood.2022017518. Acesso em: 03 jun. 2024.
APA
Gutierrez-Rodrigues, F., Munger, E., Ma, X., Patel, B. A., Catto, L. F. B., Clé, D. V., et al. (2023). Differential diagnosis of bone marrow failure syndromes guided by machine learning. Blood, 141( 17), 2100-2113. doi:10.1182/blood.2022017518
NLM
Gutierrez-Rodrigues F, Munger E, Ma X, Patel BA, Catto LFB, Clé DV, Paiva R de MA, Donaires FS, Pinto AL, Borges G, Santana BAA, Pasquini R, Velloso EDRP, Calado RT. Differential diagnosis of bone marrow failure syndromes guided by machine learning [Internet]. Blood. 2023 ; 141( 17): 2100-2113.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2022017518
Vancouver
Gutierrez-Rodrigues F, Munger E, Ma X, Patel BA, Catto LFB, Clé DV, Paiva R de MA, Donaires FS, Pinto AL, Borges G, Santana BAA, Pasquini R, Velloso EDRP, Calado RT. Differential diagnosis of bone marrow failure syndromes guided by machine learning [Internet]. Blood. 2023 ; 141( 17): 2100-2113.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2022017518
Artigo de periodico
Spectrum of clonal hematopoiesis in VEXAS syndrome (2023)
Gutierrez-Rodrigues, Fernanda ; Kusne, Yael; Fernandez, Jenna; Lasho, Terra L; Shalhoub, Ruba N; Koster, Matthew J.; Begna, Kebede; Ombrello, Amanda K; Ferrada, Marcela A.; Wilson, Lorena; Calado, Rodrigo Tocantins
Source: Blood. Unidade: FMRP
Subjects: HEMATOPOESE, DERMATITE, MUTAÇÃO, ESTUDOS PROSPECTIVOS, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ-RODRIGUES, Fernanda et al. Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood, v. 142, n. 3, p. 244-259, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood.2022018774. Acesso em: 03 jun. 2024.
APA
Gutierrez-Rodrigues, F., Kusne, Y., Fernandez, J., Lasho, T. L., Shalhoub, R. N., Koster, M. J., et al. (2023). Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood, 142( 3), 244-259. doi:10.1182/blood.2022018774
NLM
Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho TL, Shalhoub RN, Koster MJ, Begna K, Ombrello AK, Ferrada MA, Wilson L, Calado RT. Spectrum of clonal hematopoiesis in VEXAS syndrome [Internet]. Blood. 2023 ; 142( 3): 244-259.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2022018774
Vancouver
Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho TL, Shalhoub RN, Koster MJ, Begna K, Ombrello AK, Ferrada MA, Wilson L, Calado RT. Spectrum of clonal hematopoiesis in VEXAS syndrome [Internet]. Blood. 2023 ; 142( 3): 244-259.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2022018774
Artigo de periodico
Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Nascimento, Mariane Cristina do ; Nogueira, Frederico Lisboa ; Medeiros, Rita de Cássia Cavaglieri ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, HEMATOLOGIA, LEUCEMIA MIELOIDE AGUDA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS, PROTEÍNAS, CÉLULAS MIELOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, v. 142, n. Supl. 1, p. 5774, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189998. Acesso em: 03 jun. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Martins, D. A. P., Nascimento, M. C. do, Nogueira, F. L., Medeiros, R. de C. C., et al. (2023). Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, 142( Supl. 1), 5774. doi:10.1182/blood-2023-189998
NLM
Lima KC de, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-189998
Vancouver
Lima KC de, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-189998
Artigo de periodico
Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models (2023)
Nascimento, Mariane Cristina do ; Martins, Diego Antonio Pereira ; Alcântara, Guilherme Augusto Sousa; Lima, Keli Cristina de ; Vicari, Hugo Passos ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Ferreira, Marcelo José Pena ; Costa-Lotufo, Leticia Veras ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: IB, FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HEMATOLOGIA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, APOPTOSE, DANO AO DNA, MITOCÔNDRIAS, PROTEÔMICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Mariane Cristina do et al. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, v. 142, n. res. 604, p. 5751, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189814. Acesso em: 03 jun. 2024.
APA
Nascimento, M. C. do, Martins, D. A. P., Alcântara, G. A. S., Lima, K. C. de, Vicari, H. P., Huls, G. A., et al. (2023). Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, 142( res. 604), 5751. doi:10.1182/blood-2023-189814
NLM
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-189814
Vancouver
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2023-189814
Artigo de periodico-carta/editorial
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] (2023)
Gurnari, Carmelo; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Durmaz, Arda; Pinto, André Luiz; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Visconte, Valeria; Soulier, Jean; Calado, Rodrigo Tocantins
Source: Blood. Unidade: FMRP
Subjects: ANEMIA, NEOPLASIAS, DOENÇAS RARAS, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood.2023020108. Acesso em: 03 jun. 2024. , 2023
APA
Gurnari, C., Prata, P. H. de L., Catto, L. F. B., Durmaz, A., Pinto, A. L., Inacio, M. C. B., et al. (2023). IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood.2023020108
NLM
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2023020108
Vancouver
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2023020108
Artigo de periodico
Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia (2022)
Lima, Keli ; Pereira-Martins Diego A. ; Miranda, Lívia Bassani Lins de ; Coelho-Silva, Juan L. ; Leandro, Giovana da Silva ; Isabel Weinhäuser ; Cavaglieri, Rita de Cássia ; Silva, Wellington F.; Leal, Aline Medeiros; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo M. ; Machado Neto, João Agostinho
Source: Blood. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, AMINOÁCIDOS, PROTEÍNAS QUINASES, DANO AO DNA, MITOCÔNDRIAS, HOMEOSTASE, LISOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia. Blood, v. 140, p. 5965–5966, 2022Tradução . . Disponível em: https://doi.org/10.1182/blood-2022-165172. Acesso em: 03 jun. 2024.
APA
Lima, K., Pereira-Martins Diego A.,, Miranda, L. B. L. de, Coelho-Silva, J. L., Leandro, G. da S., Isabel Weinhäuser,, et al. (2022). Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia. Blood, 140, 5965–5966. doi:10.1182/blood-2022-165172
NLM
Lima K, Pereira-Martins Diego A., Miranda LBL de, Coelho-Silva JL, Leandro G da S, Isabel Weinhäuser, Cavaglieri R de C, Silva WF, Leal AM, Lange APA de L, Velloso EDRP, Griessinger E, Hilberink JR, Huls GA, Schuringa JJ, Rego EM, Machado Neto JA. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia [Internet]. Blood. 2022 ; 140 5965–5966.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2022-165172
Vancouver
Lima K, Pereira-Martins Diego A., Miranda LBL de, Coelho-Silva JL, Leandro G da S, Isabel Weinhäuser, Cavaglieri R de C, Silva WF, Leal AM, Lange APA de L, Velloso EDRP, Griessinger E, Hilberink JR, Huls GA, Schuringa JJ, Rego EM, Machado Neto JA. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia [Internet]. Blood. 2022 ; 140 5965–5966.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2022-165172
Trabalho de evento-resumo periodico
Immune dysregulation in human telomere diseases (2022)
Gomes, Willian Robert; Carvalho, Vinícius Silva de; Santana, Bárbara Amélia Aparecida; Martinez, Edson Zangiacomi ; Ramalho, Leandra Naíra Zambelli; Condino Neto, Antonio; Rodrigues, Rodrigo do Tocantins Calado de Saloma
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FMRP, ICB
Subjects: IMUNOLOGIA, TELÔMERO, BIOMARCADORES, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Willian Robert et al. Immune dysregulation in human telomere diseases. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-169926. Acesso em: 03 jun. 2024. , 2022
APA
Gomes, W. R., Carvalho, V. S. de, Santana, B. A. A., Martinez, E. Z., Ramalho, L. N. Z., Condino Neto, A., & Rodrigues, R. do T. C. de S. (2022). Immune dysregulation in human telomere diseases. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-169926
NLM
Gomes WR, Carvalho VS de, Santana BAA, Martinez EZ, Ramalho LNZ, Condino Neto A, Rodrigues R do TC de S. Immune dysregulation in human telomere diseases [Internet]. Blood. 2022 ; 140 8668-8670.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2022-169926
Vancouver
Gomes WR, Carvalho VS de, Santana BAA, Martinez EZ, Ramalho LNZ, Condino Neto A, Rodrigues R do TC de S. Immune dysregulation in human telomere diseases [Internet]. Blood. 2022 ; 140 8668-8670.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2022-169926
Trabalho de evento-resumo periodico
Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia (2022)
Kerbauy, Lucila; Okamoto, Oswaldo Keith
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: IB
Subjects: CÉLULAS, VETORES, CULTURA DE CÉLULAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KERBAUY, Lucila e OKAMOTO, Oswaldo Keith. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia. Blood. Washington: Instituto de Biociências, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-170045. Acesso em: 03 jun. 2024. , 2022
APA
Kerbauy, L., & Okamoto, O. K. (2022). Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia. Blood. Washington: Instituto de Biociências, Universidade de São Paulo. doi:10.1182/blood-2022-170045
NLM
Kerbauy L, Okamoto OK. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia [Internet]. Blood. 2022 ; 40( 1):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2022-170045
Vancouver
Kerbauy L, Okamoto OK. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia [Internet]. Blood. 2022 ; 40( 1):[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2022-170045
Artigo de periodico
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC (2022)
Olsen, Elise A. ; Whittaker, Sean; Willemze, Rein ; Pinter-brown, Lauren; Foss, Francine ; Geskin, Larisa; Schwartz, Lawrence; Horwitz, Steven; Guitart, Joan; Zic, John
Source: Blood. Unidade: FM
Subjects: SINAIS E SINTOMAS, MANIFESTAÇÕES CUTÂNEAS, QUALIDADE DE VIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLSEN, Elise A. et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, v. 140, n. 5, p. 419-437, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50496. Acesso em: 03 jun. 2024.
APA
Olsen, E. A., Whittaker, S., Willemze, R., Pinter-brown, L., Foss, F., Geskin, L., et al. (2022). Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, 140( 5), 419-437. doi:10.1182/blood.2021012057
NLM
Olsen EA, Whittaker S, Willemze R, Pinter-brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [Internet]. Blood. 2022 ; 140( 5): 419-437.[citado 2024 jun. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50496
Vancouver
Olsen EA, Whittaker S, Willemze R, Pinter-brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [Internet]. Blood. 2022 ; 140( 5): 419-437.[citado 2024 jun. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50496
Trabalho de evento-resumo periodico
Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia (2020)
Oliveira, Bruno Quintino; Santana, Bárbara; Catto, Luiz Fernando Bazzo ; Tellechea, Maria Florencia; Scheucher, Priscila Santos; Scheinberg, Phillip; Calado, Rodrigo Tocantins
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: ANEMIA, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Bruno Quintino et al. Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-142746. Acesso em: 03 jun. 2024. , 2020
APA
Oliveira, B. Q., Santana, B., Catto, L. F. B., Tellechea, M. F., Scheucher, P. S., Scheinberg, P., & Calado, R. T. (2020). Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-142746
NLM
Oliveira BQ, Santana B, Catto LFB, Tellechea MF, Scheucher PS, Scheinberg P, Calado RT. Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia [Internet]. Blood. 2020 ; 136 [3] .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-142746
Vancouver
Oliveira BQ, Santana B, Catto LFB, Tellechea MF, Scheucher PS, Scheinberg P, Calado RT. Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia [Internet]. Blood. 2020 ; 136 [3] .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-142746
Artigo de periodico-carta/editorial
Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. [Carta] (2020)
Catto, Luiz Fernando Bazzo ; Borges, Gustavo; Santos, André Luiz Pinto ; Clé, Diego V.; Chahud, Fernando ; Santana, Bárbara Amélia Aparecida ; Ramos, Flávia Sacilotto Donaires ; Calado, Rodrigo Tocantins
Source: Blood. Unidade: FMRP
Subjects: HEMATOPOESE, MUTAÇÃO GENÉTICA, DOENÇAS HEREDITÁRIAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATTO, Luiz Fernando Bazzo et al. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood.2020005538. Acesso em: 03 jun. 2024. , 2020
APA
Catto, L. F. B., Borges, G., Santos, A. L. P., Clé, D. V., Chahud, F., Santana, B. A. A., et al. (2020). Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood.2020005538
NLM
Catto LFB, Borges G, Santos ALP, Clé DV, Chahud F, Santana BAA, Ramos FSD, Calado RT. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. [Carta] [Internet]. Blood. 2020 ; 136( 8): 1002-1005.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2020005538
Vancouver
Catto LFB, Borges G, Santos ALP, Clé DV, Chahud F, Santana BAA, Ramos FSD, Calado RT. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. [Carta] [Internet]. Blood. 2020 ; 136( 8): 1002-1005.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2020005538
Trabalho de evento-resumo periodico
The role of plasmin/plasminogen in experimental polymicrobial sepsis (2020)
Vago, Juliana; Brito, Larissa Froede; Teixeira, Lívia C. R.; Moreira, Izabela Z.; Miranda, Thaís C.; Melo, Eliza M.; Bruno, Alexandre S.; Sugimoto, Michelle A.; Ferreira, Raphael G.; Alves Filho, José Carlos Farias ; Teixeira, Mauro M.; Parmer, Robert J; Miles, Lindsey A.; Sousa, Lirlandia P.
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: SEPSE, MORTALIDADE, NEUTRÓFILOS, ENZIMAS, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAGO, Juliana et al. The role of plasmin/plasminogen in experimental polymicrobial sepsis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-139180. Acesso em: 03 jun. 2024. , 2020
APA
Vago, J., Brito, L. F., Teixeira, L. C. R., Moreira, I. Z., Miranda, T. C., Melo, E. M., et al. (2020). The role of plasmin/plasminogen in experimental polymicrobial sepsis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-139180
NLM
Vago J, Brito LF, Teixeira LCR, Moreira IZ, Miranda TC, Melo EM, Bruno AS, Sugimoto MA, Ferreira RG, Alves Filho JCF, Teixeira MM, Parmer RJ, Miles LA, Sousa LP. The role of plasmin/plasminogen in experimental polymicrobial sepsis [Internet]. Blood. 2020 ; 136 16-17.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-139180
Vancouver
Vago J, Brito LF, Teixeira LCR, Moreira IZ, Miranda TC, Melo EM, Bruno AS, Sugimoto MA, Ferreira RG, Alves Filho JCF, Teixeira MM, Parmer RJ, Miles LA, Sousa LP. The role of plasmin/plasminogen in experimental polymicrobial sepsis [Internet]. Blood. 2020 ; 136 16-17.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-139180
Trabalho de evento-resumo periodico
Burden of sickle cell disease: a Brazilian societal perspective analysis (2020)
Pinto, Ana Cristina Silva; Costa, Fernando Ferreira; Gualandro, Sandra Fátima Menosi ; Fonseca, Patricia Belintani Blum; Bueno, Carolina Tosin; Cançado, Rodolfo D.
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FMRP, FM
Subjects: HEMATOLOGIA, ANEMIA FALCIFORME, CUSTOS DOS CUIDADOS DE SAÚDE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Ana Cristina Silva et al. Burden of sickle cell disease: a Brazilian societal perspective analysis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-136168. Acesso em: 03 jun. 2024. , 2020
APA
Pinto, A. C. S., Costa, F. F., Gualandro, S. F. M., Fonseca, P. B. B., Bueno, C. T., & Cançado, R. D. (2020). Burden of sickle cell disease: a Brazilian societal perspective analysis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-136168
NLM
Pinto ACS, Costa FF, Gualandro SFM, Fonseca PBB, Bueno CT, Cançado RD. Burden of sickle cell disease: a Brazilian societal perspective analysis [Internet]. Blood. 2020 ; 136 10-11.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-136168
Vancouver
Pinto ACS, Costa FF, Gualandro SFM, Fonseca PBB, Bueno CT, Cançado RD. Burden of sickle cell disease: a Brazilian societal perspective analysis [Internet]. Blood. 2020 ; 136 10-11.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-136168
Trabalho de evento-resumo periodico
Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) (2020)
Kassim, Adetola A.; de la Fuente, Josu; Alahmari, Ali Debsan; Eckrich, Michael J.; Hanna, Rabi; Dhedin, Nathalie; Horn, Biljana N.; Black, Vandy; Gouveia, Roseane V.; Seber, Adriana; Simões, Belinda Pinto ; Costa, Thalita Cristina de Mello; Cunha, Renato Luiz Guerino
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: TRANSPLANTE DE MEDULA ÓSSEA, HEMATOLOGIA, ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KASSIM, Adetola A. et al. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-141771. Acesso em: 03 jun. 2024. , 2020
APA
Kassim, A. A., de la Fuente, J., Alahmari, A. D., Eckrich, M. J., Hanna, R., Dhedin, N., et al. (2020). Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-141771
NLM
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-141771
Vancouver
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2020-141771
Artigo de periodico
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study (2019)
Lee, Jong Wook; Fontbrune, Flore Sicre de; Lee, Lily Wong Lee; Pessoa, Viviani; Gualandro, Sandra Fátima Menosi; Fuereder, Wolfgang; Ptushkin, Vadim; Rottinghaus, Scott T; Volles, Lori; Shafner, Lori
Source: Blood. Unidade: FM
Subjects: DOENÇAS HEMATOLÓGICAS, ANTICORPOS MONOCLONAIS, ADULTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Jong Wook et al. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood, v. 133, n. 6, p. 530-539, 2019Tradução . . Disponível em: https://doi.org/10.1182/blood-2018-09-876136. Acesso em: 03 jun. 2024.
APA
Lee, J. W., Fontbrune, F. S. de, Lee, L. W. L., Pessoa, V., Gualandro, S. F. M., Fuereder, W., et al. (2019). Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood, 133( 6), 530-539. doi:10.1182/blood-2018-09-876136
NLM
Lee JW, Fontbrune FS de, Lee LWL, Pessoa V, Gualandro SFM, Fuereder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study [Internet]. Blood. 2019 ; 133( 6): 530-539.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-876136
Vancouver
Lee JW, Fontbrune FS de, Lee LWL, Pessoa V, Gualandro SFM, Fuereder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study [Internet]. Blood. 2019 ; 133( 6): 530-539.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-876136
Artigo de periodico
Novel pathways of self- and cross-tolerance in monocytes (2019)
Farsky, Sandra Helena Poliselli
Source: Blood. Unidade: FCF
Subjects: MONÓCITOS, SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARSKY, Sandra Helena Poliselli. Novel pathways of self- and cross-tolerance in monocytes. Blood, v. 134, n. 2, p. 101-103, 2019Tradução . . Disponível em: https://doi.org/10.1182/blood.2019001532. Acesso em: 03 jun. 2024.
APA
Farsky, S. H. P. (2019). Novel pathways of self- and cross-tolerance in monocytes. Blood, 134( 2), 101-103. doi:10.1182/blood.2019001532
NLM
Farsky SHP. Novel pathways of self- and cross-tolerance in monocytes [Internet]. Blood. 2019 ; 134( 2): 101-103.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2019001532
Vancouver
Farsky SHP. Novel pathways of self- and cross-tolerance in monocytes [Internet]. Blood. 2019 ; 134( 2): 101-103.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood.2019001532
Artigo de periodico-carta/editorial
Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] (2019)
Campos, Lívia Weijenborg; Zenatti, Priscila Pini ; Pissinato, Leonardo Granato ; Rodrigues, Gisele Olinto Libanio; Artico, Leonardo Luís ; Guimarães, Thais Rafael; Archangelo, Leticia Fröhlich ; Martínez, Leandro ; Brooks, Andrew J.; Yunes, Jose Andres
Source: Blood. Unidade: FMRP
Subjects: ONCOGENES, AMINOÁCIDOS, HIPERSENSIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Lívia Weijenborg et al. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2018-09-872945. Acesso em: 03 jun. 2024. , 2019
APA
Campos, L. W., Zenatti, P. P., Pissinato, L. G., Rodrigues, G. O. L., Artico, L. L., Guimarães, T. R., et al. (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2018-09-872945
NLM
Campos LW, Zenatti PP, Pissinato LG, Rodrigues GOL, Artico LL, Guimarães TR, Archangelo LF, Martínez L, Brooks AJ, Yunes JA. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] [Internet]. Blood. 2019 ; 133( 11): 1259-1263.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-872945
Vancouver
Campos LW, Zenatti PP, Pissinato LG, Rodrigues GOL, Artico LL, Guimarães TR, Archangelo LF, Martínez L, Brooks AJ, Yunes JA. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] [Internet]. Blood. 2019 ; 133( 11): 1259-1263.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-872945
Artigo de periodico
Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation (2017)
Gluckman, Eliane; Cappelli, Barbara; Bernaudin, Francoise; Labopin, Myriam; Volt, Fernanda; Carreras, Jeanette; Simões, Belinda Pinto; Ferster, Alina; Dupont, Sophie; Fuente, Josu de la; Dalle, Jean-Hugues; Zecca, Marcos; Walters, Mark C.; Krishnamurti, Lakshmanan; Bhatia, Monica; Leung, Kathryn; Yanik, Gregory; Kurtzberg, Joanne; Dhedin, Nathalie; Kuentz, Mathieu; Michel, Gerard; Apperley, Jane; Lutz, Patrick; Neven, Bénédicte; Bertrand, Ives; Vannier, Jean Pierre; Ayas, Mouhab; Cavazzana, Marina; Martin, Susanne Matthes; Rocha, Vanderson Amadeu da; Kenzey, Chantal; Bader, Peter; Locatelli, Franco; Ruggeri, Annalisa; Eapen, Mary
Source: Blood. Unidade: FM
Subjects: ANEMIA FALCIFORME, DOENÇAS HEMATOLÓGICAS, CÉLULAS, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLUCKMAN, Eliane et al. Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood, v. 129, n. 11, p. 1548-1556, 2017Tradução . . Disponível em: https://doi.org/10.1182/blood-2016-10-745711. Acesso em: 03 jun. 2024.
APA
Gluckman, E., Cappelli, B., Bernaudin, F., Labopin, M., Volt, F., Carreras, J., et al. (2017). Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood, 129( 11), 1548-1556. doi:10.1182/blood-2016-10-745711
NLM
Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Simões BP, Ferster A, Dupont S, Fuente J de la, Dalle J-H, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand I, Vannier JP, Ayas M, Cavazzana M, Martin SM, Rocha VA da, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M. Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation [Internet]. Blood. 2017 ; 129( 11): 1548-1556.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2016-10-745711
Vancouver
Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Simões BP, Ferster A, Dupont S, Fuente J de la, Dalle J-H, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand I, Vannier JP, Ayas M, Cavazzana M, Martin SM, Rocha VA da, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M. Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation [Internet]. Blood. 2017 ; 129( 11): 1548-1556.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1182/blood-2016-10-745711

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration